These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25605615)

  • 1. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.
    McLaren CE; Emond MJ; Subramaniam VN; Phatak PD; Barton JC; Adams PC; Goh JB; McDonald CJ; Powell LW; Gurrin LC; Allen KJ; Nickerson DA; Louie T; Ramm GA; Anderson GJ; McLaren GD
    Hepatology; 2015 Aug; 62(2):429-39. PubMed ID: 25605615
    [TBL] [Abstract][Full Text] [Related]  

  • 2.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.
    Secondes ES; Wallace DF; Rishi G; McLaren GD; McLaren CE; Chen WP; Ramm LE; Powell LW; Ramm GA; Barton JC; Subramaniam VN
    Blood Cells Mol Dis; 2020 Nov; 85():102463. PubMed ID: 32652459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.
    Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S
    Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gnpat does not play an essential role in systemic iron homeostasis in murine model.
    An P; Wang J; Wang H; Jiang L; Wang J; Min J; Wang F
    J Cell Mol Med; 2020 Apr; 24(7):4118-4126. PubMed ID: 32108988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
    Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
    Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNPAT variant associated with severe iron overload in HFE hemochromatosis.
    Bardou-Jacquet E; de Tayrac M; Mosser J; Deugnier Y
    Hepatology; 2015 Dec; 62(6):1917-8. PubMed ID: 25891252
    [No Abstract]   [Full Text] [Related]  

  • 9. GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.
    Barton JC; Chen WP; Emond MJ; Phatak PD; Subramaniam VN; Adams PC; Gurrin LC; Anderson GJ; Ramm GA; Powell LW; Allen KJ; Phillips JD; Parker CJ; McLaren GD; McLaren CE
    Blood Cells Mol Dis; 2017 Mar; 63():15-20. PubMed ID: 27936396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
    Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
    Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
    Aguilar-Martinez P; Grandchamp B; Cunat S; Cadet E; Blanc F; Nourrit M; Lassoued K; Schved JF; Rochette J
    Haematologica; 2011 Apr; 96(4):507-14. PubMed ID: 21228038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda.
    Farrell CP; Overbey JR; Naik H; Nance D; McLaren GD; McLaren CE; Zhou L; Desnick RJ; Parker CJ; Phillips JD
    PLoS One; 2016; 11(9):e0163322. PubMed ID: 27661980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated hepcidin response to dietary iron in male mice with reduced Gnpat expression.
    Rishi G; Secondes ES; Asplett K; Wallace DF; Ostini L; Berger J; Subramaniam VN
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.